🔗 Share this article

An underground economy for unlicensed weight-loss drugs is propelled by social media fitness personalities and vendors on messaging platforms, according to new investigations.

Experimental Drug Gaining Popularity Online

Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its alleged weight-reducing effects. Followers are encouraged to message these accounts privately for supplier links, while also obtaining promotional offers.

Active Commerce on Social Networks

Separately, a flourishing trade exists on Telegram, where communities with thousands of participants share comparison photos, administration instructions and claims of next-day British shipping. Sellers market the substance there before redirecting customers to other platforms for purchases.

Learning About The Experimental Drug

Retatrutide is an experimental injectable created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials suggest it could assist individuals reduce up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the next Ozempic.

Healthcare Professionals Voice Concerns

Nevertheless, physicians and pharmacists have warned that the distribution of what is still an unapproved drug in the UK is a cause for concern and could lead to users administering substances of unknown origin.

Several professionals said the demand for the experimental drug could be connected to the rising price of licensed slimming products such as Mounjaro.

Legal Position and Enforcement

Selling retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed medication that cannot be marketed or supplied for human use under the Human Medicines Regulations 2012.

Some influencers attempt to circumvent the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still breach medicines, advertising, and consumer laws, risking fines, prosecution or prison.

Service Response and Content Elimination

According to TikTok, the service has removed problematic content and banned associated keywords and search suggestions. The organization stated it was committed to maintaining the platform secure and investing in strengthening compliance measures.

Online Trading Operations

Research also found groups with up to 9,000 participants marketing the experimental drug using the platform's integrated discovery tool, which operates like a online catalog. Entering “retatrutide” immediately brings up groups with numerous of users, filled with photos of slimming results, glowing reviews and detailed instructions for preparing or administering at home.

Within moments of entering one group, a vendor shared contact information, where the majority of purchases occur. The vendor sent an instruction manual and promised delivery within 48 hours. When asked whether the product was genuine, one vendor said: “You can’t be sure.” Another provided a image of a alleged testing documentation. Not one inquired about weight, health issues or previous experience.

Product Information and Pricing

Inside these groups, posts display black plastic packages with postal service labels, claiming to include new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at residence with purified liquid, or pre-filled injectors typically priced at £160 for 20 milligrams. When questioned how long a injector should be used, vendors give conflicting answers varying between a several days to “depends on your body”.

Service Moderation and Security Actions

A spokesperson for the messaging service said it actively monitored dangerous content on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are injecting substances they can’t verify. Even if the science behind retatrutide is valid, these digital versions may not contain what they advertise,” said Jason Murphy, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the increase in interest to recent price rises for approved slimming drugs such as Mounjaro. “With costs rising, patients are using social media. But fake treatments are highly risky. You cannot know what’s contained or whether the conditions they were made in was sterile,” she said.

Her staff has previously encountered patients harmed by personal administration from unverified sources. “We understand the frustration, but purchasing from Telegram or WhatsApp is gambling with your health,” said the doctor. “These materials could be contaminated or incorrectly dosed.”

Producer Position

A representative from Eli Lilly said retatrutide was in phase 3 research studies and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they said, adding that any item “misleadingly claiming itself as a company experimental substance not yet approved … may expose patients to potentially serious health risks”.